Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma

Masahiko Koda, Yoshikazu Murawaki, Akeri Mitsuda, +5

Cancer

Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma

Masahiko Koda, Yoshikazu Murawaki, Akeri Mitsuda, +5

Cancer

Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients

Masaki Maeda, Issei Saeki, Isao Sakaida, +28

Liver Cancer

Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group

Toshie Mashiba, Kouji Joko, Masayuki Kurosaki, +22

PLoS ONE

The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study

Kaoru Tsuchiya, Masayuki Kurosaki, Azusa Sakamoto, +23

Cancers

Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group

Keiji Tsuji, Masayuki Kurosaki, Jun Itakura, +20

Journal of Gastroenterology

HepatologyHepatitis CViral HepatitisAntiviral TherapyHepatitis +6

Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment Failure

Jun Itakura, Masayuki Kurosaki, Chitomi Hasebe, +20

PLoS ONE

Real‐world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group

Takehiro Akahane, Masayuki Kurosaki, Jun Itakura, +23

Hepatology Research

Real‐world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1‐ and 2‐infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group

Toshifumi Tada, Masayuki Kurosaki, Shinichiro Nakamura, +21

Journal of Medical Virology

Velpatasvir TreatmentHcv Genotype 1‐Viral HepatitisClinical EpidemiologyPublic Health +14

Changes in serum tissue inhibitor of matrix metalloproteinase-1 after interferon alpha treatment in chronic hepatitis C

Akeri Mitsuda, Takeaki Suou, Yujiro Ikuta, +1

Journal of Hepatology

InflammationAutoimmune DiseaseHepatologyHepatitis CViral Hepatitis +12